Company Overview of Spear Therapeutics Ltd.
Spear Therapeutics, Ltd. develops prodrugs for the treatment of cancer. It offers cytochrome P450 (CYP)-activated prodrugs, which include aromatic hydroxylation activators, nitric/nitrogen oxide release agents, and compounds possessing specific CYP enzyme-activated drug release activity. The company was incorporated in 2002 and is based in London, the United Kingdom.
Founded in 2002
Key Executives for Spear Therapeutics Ltd.
Similar Private Companies By Industry
|ProMetic BioSciences Ltd.||Europe|
|Aventis Pharma Ltd.||Europe|
|CoCo Therapeutics Ltd||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Princeton, NJ | RGPPosted: Dec 13
- Princeton, NJ | RGPPosted: Nov 27
- Princeton, NJ | RGPPosted: Oct 21
- Remote, OR | ForestPosted: Dec 13
Sponsored Financial Commentaries
To contact Spear Therapeutics Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.